Observational study 2026

Three-year efficacy and safety of repeated low-level red-light therapy for myopia control: a multicentre real-world study

Yanping Chen; Wei Wang; Ruilin Xiong; Fang Yu; Shaoxin Pan; Jing Dong; Jian Zhang; Zhuoting Zhu; Xiaohu Ding; Bin Wang; Yanxian Chen; Henry Ho-lung Chan; Kai Yip Choi; Sonia Seen Hang Chan; Yingfeng Zheng; Danli Shi; Yuri Aung; Shoji Kishi; Kyoko Ohno-Matsui; Mingguang He

The British journal of ophthalmology

What does this source bring?

The real-world study includes groups with varying durations of RLRL use, including 91 participants treated with 3 for at least a year.

These are groups by length of treatment, not a three-year RCT. Possible selection of continuators. Median in the longest group 3,65 of the year.

CLAIM-RLRL-THREE

Scope of testing and verification

The role of the record
Source of the claim
Population
Children and adolescents 7–18 years, three hospitals
N
362
Geography
China
Observation (months)
44
Comparator
Brak losowej grupy kontrolnej
Result
The real-world study includes groups with varying durations of RLRL use, including 91 participants treated with 3 for at least a year.
Safety
OCT and ERG were evaluated; minimal reversible OCT changes in four eyes without affecting visual function.
Device/structure
Not applicable / not determined within the verified range
Publisher of the publication
BMJ
Financing
Not determined within the proven range; see the declaration in full text.
Conflicts of interest
Not determined within the proven range. The absence of confirmation does not mean the absence of conflict.
DOI
10.1136/bjo-2025-328687
PMID
41558834
What was checked
Bibliographic metadata and abstract in Europe PMC / PubMed
Date of verification
2026-09-09

This is the editorial card of the publication. The description does not replace the full text, supplementary data or instructions for a specific device.

Availability

Text size
100%
Contrast
Reading
SOURCE RECORD

Source record